CIK: 1190637 - Address: C/o Arcturus Therapeutics Holdings Inc., 10628 Science Center Drive, Suite 250, San Diego, CA 92121
30 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1117024211207
S%wins53293535292434

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/13/14 17:54
2/12/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d1,57465.9233249D226121411913441015128847
2/13/14 17:54
2/12/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-2,949123.5233-24-729D226121411913441015128847
3/28/12 18:18
3/26/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d1,13564.47331810D5919-771115131211382640
3/28/12 18:18
3/26/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-1,66494.5333-18-6310D5919-771115131211382640
3/15/12 13:48
3/13/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d29159.133359010D467-11-3010-1-1814153853
3/15/12 13:48
3/13/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-45993.1933-5-3210D467-11-3010-1-1814153853
3/9/12 18:47
3/8/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-88491.2833-10-4810D442-13-60-30-20-112164052
3/9/12 18:47
3/8/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d22440.1633611510D442-13-60-30-20-112164052
4/12/11 19:32
4/11/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS-2675.09330-214D9536288453-1209191616
2/28/11 19:45
2/25/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d29159.133355314D9540301260-11-11014154
2/28/11 19:45
2/25/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-39574.0933-5-2714D9540301260-11-11014154
2/24/11 19:23
2/23/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d50248.62331023915D8439301040-4-211012176
2/24/11 19:23
2/23/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-86073.5433-12-4415D8439301040-4-211012176
1/20/11 19:50
1/18/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS-7272.0933-1-714D1202621125200266103114
9/16/10 20:09
9/15/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d1,98155.47333615D46206-241-40029152554
9/16/10 20:09
9/15/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-2,36266.1233-36-7115D46206-241-40029152554
5/17/10 18:30
5/13/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d8440.163321715D503818121-1-2-1014-22048
5/17/10 18:30
5/13/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-13363.3533-2-1315D503818121-1-2-1014-22048
2/23/10 20:29
2/19/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-6059.5433-1-617D44321210034223610843
8/5/09 19:47
8/4/09
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d45237.52331230616D1220271710521-11021419
8/5/09 19:47
8/4/09
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-66955.4933-12-4316D1220271710521-11021419
8/18/08 14:52
8/14/08
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS-16856.1433-3-1913D24010713558-10-7-22-713
5/10/07 20:00
5/9/07
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d42070.823361719D7420121915150112-1-3-8
5/10/07 20:00
5/9/07
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-731123.4033-6-399D7420121915150112-1-3-8
4/5/06 20:04
4/3/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d36679.493053346B-2-60-19-9-8
4/5/06 20:04
4/3/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-501109.0030-5-436B-2-60-19-9-8
3/31/06 20:52
3/29/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpM.d67463.5930116B1-11-18-10-8
3/31/06 20:52
3/29/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOSVP,CorpS.d-1,156109.0030-11-646B1-11-18-10-8
2/10/04 18:01
2/6/04
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOVP,CorpoM.d48663.543385D756624125-11313-6-28-45-39
2/10/04 18:01
2/6/04
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsBarlow James FCAOVP,CorpoS.d-66286.5033-8-585D756624125-11313-6-28-45-39

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact